Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinoma

被引:5
|
作者
Nan, Yuemin [1 ]
Zhao, Suxian [1 ]
Zhang, Xiaoxiao [1 ]
Xiao, Zhifeng [2 ]
Guo, Ruihan [3 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Hebei Prov Key Lab Liver Fibrosis Chron Liver Dis, Shijiazhuang, Peoples R China
[2] Behrend Coll, Sch Engn, Penn State Erie, Erie, PA USA
[3] Shanghai Ashermed Healthcare Co Ltd, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
hepatocellular carcinoma; blood biomarkers; machine learning; hepatitis B; cirrhosis; risk model; immunotherapy;
D O I
10.3389/fimmu.2022.1031400
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B Virus (HBV) infection may lead to various liver diseases such as cirrhosis, end-stage liver complications, and Hepatocellular carcinoma (HCC). Patients with existing cirrhosis or severe fibrosis have an increased chance of developing HCC. Consequently, lifetime observation is currently advised. This study gathered real-world electronic health record (EHR) data from the China Registry of Hepatitis B (CR-HepB) database. A collection of 396 patients with HBV infection at different stages were obtained, including 1) patients with a sustained virological response (SVR), 2) patients with HBV chronic infection and without further development, 3) patients with cirrhosis, and 4) patients with HCC. Each patient has been monitored periodically, yielding multiple visit records, each is described using forty blood biomarkers. These records can be utilized to train predictive models. Specifically, we develop three machine learning (ML)-based models for three learning tasks, including 1) an SVR risk model for HBV patients via a survival analysis model, 2) a risk model to encode the progression from HBV, cirrhosis and HCC using dimension reduction and clustering techniques, and 3) a classifier to detect HCC using the visit records with high accuracy (over 95%). Our study shows the potential of offering a comprehensive understanding of HBV progression via predictive analysis and identifies the most indicative blood biomarkers, which may serve as biomarkers that can be used for immunotherapy.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Predicting quetiapine dose in patients with depression using machine learning techniques based on real-world evidence
    Hao, Yupei
    Zhang, Jinyuan
    Yu, Jing
    Yu, Ze
    Yang, Lin
    Hao, Xin
    Gao, Fei
    Zhou, Chunhua
    ANNALS OF GENERAL PSYCHIATRY, 2024, 23 (01)
  • [32] Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study
    Wu, Linghong
    Liu, Zengjing
    Huang, Hongyuan
    Pan, Dongmei
    Fu, Cuiping
    Lu, Yao
    Zhou, Min
    Huang, Kaiyong
    Huang, Tianren
    Yang, Li
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [33] A simple model based on real-world clinical data is valuable for preoperative prediction of microvascular invasion in patients with hepatocellular carcinoma
    Sun, Ying
    Zhang, Kun-He
    Wang, Ting
    Zhang, Hong-Li
    Li, Zi-Hua
    Luo, Qing-Qing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 62 - 63
  • [34] A simple model based on real-world clinical data is valuable for preoperative prediction of microvascular invasion in patients with hepatocellular carcinoma
    Sun, Ying
    Zhang, Kun-He
    Wang, Ting
    Zhang, Hong-Li
    Li, Zi-Hua
    Luo, Qing-Qing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 62 - 63
  • [35] Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence Comment
    Zhu, Yuxiang
    Wang, Xuebin
    Wang, Xue
    Chen, Lizhi
    Wang, Zhuo
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Optimize nucleot(s)ide analogues' to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence
    Lim, Jihye
    Choi, Jonggi
    HEPATOMA RESEARCH, 2021, 7
  • [37] Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence
    Yang, Lin
    Zhang, Jinyuan
    Yu, Jing
    Yu, Ze
    Hao, Xin
    Gao, Fei
    Zhou, Chunhua
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (08) : 741 - 750
  • [38] Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
    prelaj, A.
    Galli, E. G.
    Pesenti, M.
    Viscardi, G.
    Bottiglieri, A.
    Marinacci, R.
    Pedica, B.
    Proto, C.
    Ferrara, R.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    Manglaviti, S.
    Galli, G.
    Mazzeo, L.
    Beninato, T.
    Pircher, C. C.
    Di Mauro, M. R.
    Ganzinelli, M.
    Di Nucci, A.
    Dumitrascu, A. D.
    Di Gregorio, S.
    De Braud, F. M. G.
    Garassino, M. C.
    Restelli, M.
    Lo Russo, G.
    Trovo', F.
    Pedrocchi, A. L. G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S337 - S338
  • [39] Machine Learning Based Monitoring of the Pneumatic Actuators' Behavior Through Signal Processing Using Real-World Data Set
    Kovacs, Tibor
    Ko, Andrea
    FUTURE DATA AND SECURITY ENGINEERING (FDSE 2019), 2019, 11814 : 33 - 44
  • [40] Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers
    Yi-Ju Tseng
    Yi-Cheng Wang
    Pei-Chun Hsueh
    Chih-Ching Wu
    BMC Oral Health, 22